Human Papillomavirus Vaccine: The Cancer Prevention Moonshot.
Obstet Gynecol Clin North Am
; 50(2): 339-348, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37149314
ABSTRACT
Cervical cancer is the fourth most common cancer in women worldwide with immense associated morbidity and mortality. Although most of the cervical cancer cases are caused by the human papillomavirus (HPV) and can effectively be prevented by HPV vaccination, vaccination unfortunately remains underused on a global scale with vast inequities in distribution. A vaccine as a tool to prevent cancer, cervical and others, is largely unprecedented. Then why do HPV vaccination rates globally remain so low? This article explores the burden of disease, development of the vaccine and its subsequent uptake, cost-effectiveness, and associated equity issues.
Key words
Full text:
1
Collection:
01-internacional
Health context:
1_ASSA2030
/
2_ODS3
/
6_ODS3_enfermedades_notrasmisibles
Database:
MEDLINE
Main subject:
Uterine Cervical Neoplasms
/
Papillomavirus Infections
/
Papillomavirus Vaccines
Limits:
Female
/
Humans
Language:
En
Journal:
Obstet Gynecol Clin North Am
Year:
2023
Document type:
Article